News-Medical.Net

Artificial lung keeps patient alive after lung removal

Researchers evaluate the effectiveness of a novel extracorporeal total artificial lung system to enable bilateral pneumonectomy in patients with severe ARDS.
The Lancet

Microenvironmental niches dictate divergent fibroblast fates in reversible versus progressive lung fibrosis

fKey Research Laboratory for Infectious Disease Prevention for State Administration of Traditional Chinese Medicine, Tianjin Institute of Respiratory Diseases, Tianjin, China gTianjin Key Laboratory ...
Le Lézard

Savara Announces Amendment to Hercules Capital Debt Facility Providing up to $75M of Additional Debt Funding Upon U.S. Food and Drug Administration (FDA) Approval of MOLBREEVI*

Savara Inc. (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the amendment of its loan and security agreement with Hercules Capital, Inc.
Infectious Disease Advisor

ATS/ERS Issue Interstitial Pneumonia Classification Update

The ATS/ERS 2025 statement on interstitial pneumonia classification updates the 2013 statement, with insights on secondary ...
Frontiers

Mitochondrial respiratory dysfunctions of alveolar macrophages in interstitial lung disease: An exploratory study of bioenergetic and clinical links

The final, formatted version of the article will be published soon. Background: Intracellular metabolism is essential for macrophage function. However, the association between the metabolic profile of ...
Frontiers

Lung epithelial and alveolar macrophage-like cell interactions significantly modify innate responses to bacterial endotoxin with the involvement of direct cellular contacts ...

Introduction: Lung alveolar macrophages (AMs) and epithelial cells form the first line of defense against inhaled pathogens. Their interactions strongly influence innate immune responses in the lung, ...